Skip to Content

Vanguard Value Index I VIVIX

Medalist Rating as of | See Vanguard Investment Hub
  • NAV / 1-Day Return 64.08  /  +0.55 %
  • Total Assets 168.5 Bil
  • Adj. Expense Ratio
    0.040%
  • Expense Ratio 0.040%
  • Distribution Fee Level Low
  • Share Class Type Institutional
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 5.0 Mil
  • Status Open
  • TTM Yield 2.46%
  • Turnover 10%

USD | NAV as of Jul 12, 2024 | 1-Day Return as of Jul 12, 2024, 10:16 PM GMT+0

Morningstar’s Analysis VIVIX

Will VIVIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Cheap and well-diversified value exposure.

Associate Analyst Mo'ath Almahasneh

Mo'ath Almahasneh

Associate Analyst

Summary

We have qualitatively reviewed this strategy and reaffirmed its Above Average Process and People ratings. Vanguard Value constructs a well-diversified, market-cap-weighted basket of U.S. value stocks at a rock-bottom fee, a recipe for success over the long run. The following text is from April 10, 2023.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings VIVIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 22.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Berkshire Hathaway Inc Class B

3.19 5.4 Bil
Financial Services

Broadcom Inc

3.07 5.2 Bil
Technology

JPMorgan Chase & Co

2.88 4.9 Bil
Financial Services

Exxon Mobil Corp

2.60 4.4 Bil
Energy

UnitedHealth Group Inc

2.26 3.8 Bil
Healthcare

Procter & Gamble Co

1.91 3.2 Bil
Consumer Defensive

Johnson & Johnson

1.74 2.9 Bil
Healthcare

The Home Depot Inc

1.65 2.8 Bil
Consumer Cyclical

Merck & Co Inc

1.57 2.6 Bil
Healthcare

Walmart Inc

1.44 2.4 Bil
Consumer Defensive